Key Insights

Highlights

Success Rate

82% trial completion

Published Results

16 trials with published results (20%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

13.9%

11 terminated out of 79 trials

Success Rate

81.7%

-4.8% vs benchmark

Late-Stage Pipeline

25%

20 trials in Phase 3/4

Results Transparency

33%

16 of 49 completed with results

Key Signals

16 with results82% success11 terminated

Data Visualizations

Phase Distribution

62Total
Not Applicable (17)
Early P 1 (1)
P 1 (3)
P 2 (21)
P 3 (14)
P 4 (6)

Trial Status

Completed49
Terminated11
Unknown11
Recruiting4
Withdrawn2
Suspended1

Trial Success Rate

81.7%

Benchmark: 86.5%

Based on 49 completed trials

Clinical Trials (79)

Showing 20 of 20 trials
NCT06398847Not ApplicableRecruiting

Virtual Reality (VR) Self-Hypnosis Software

NCT06171243CompletedPrimary

PK of Lidocaine/Tetracaine and PD Derived From a New Topical Formulation for Treatment of Neuropathic Pain.

NCT05817786Not ApplicableRecruitingPrimary

Treatment of Upper Limb Chronic Neuropathic Pain by Electrical Stimulation of the Brachial Plexus Nerve Roots

NCT06796595Recruiting

Perioperative Medical Program to Optimize Nerve Regeneration After Robot-assisted Laparoscopic Neurolyses of Pudendal and/or Inferior Cluneal Nerves for Chronic Neuralgias: Results After 1-year Follow-up

NCT05563636Not ApplicableCompletedPrimary

High Voltage VS Standard Voltage Radiofrequency in a Patient With Failed Back Surgery Syndrome

NCT05620225Not ApplicableCompletedPrimary

Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management

NCT05935956CompletedPrimary

Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy

NCT03973983Not ApplicableCompletedPrimary

Comparison of Ultrasound-guided Transgluteal and Finger-guided Transvaginal Pudendal Nerve Block Techniques

NCT01256593CompletedPrimary

Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)

NCT05464199Phase 1CompletedPrimary

Home-based EEG Neurofeedback for Chronic Neuropathic Pain

NCT06036043UnknownPrimary

Botulinum Toxin for Chronic Neuropathic Pain

NCT01788410Recruiting

MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine

NCT05226676Not ApplicableWithdrawn

Long-term Effects of Repetitive TMS in Chronic Neuropathic Pain in People With SCI

NCT02747758Not ApplicableTerminated

Transcranial Direct Current Stimulation (tDCS) in Chronic Neuropathy

NCT04202783Not ApplicableSuspendedPrimary

The Use of Exosomes In Craniofacial Neuralgia

NCT04066933Unknown

Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M

NCT03315598Not ApplicableCompletedPrimary

Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain

NCT04700033Not ApplicableCompletedPrimary

Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial

NCT05315596Enrolling By Invitation

Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery

NCT01899170Phase 2TerminatedPrimary

Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain

Scroll to load more

Research Network

Activity Timeline